drugset / Trial / NCT01969539

Ventilator Adapters for Combivent Respimat

NCT01969539 ↗

Phase 4 Terminated 11 enrolled Boehringer Ingelheim
Non-randomizedSingle-groupOpen-labelTreatment

Summary

The general aim of this 1-day, open label, non-randomised, trial is to characterize the performance of two adapter devices designed to permit use of the Respimat® inhaler with patients requiring mechanical ventilation.

Timeline

Start
2013-10-14
Primary completion
2014-11-20
Completion
2014-11-21

Drugs

EvaluationDrugModalityDoseRoute
Background Combivent Respimat Unknown — —